Results 141 to 150 of about 43,494 (228)

Totalsynthese von Camptothecin [PDF]

, 2022
openaire   +1 more source

Construction of aptamer functionalized camptothecin incorporated chitosan-palladium/gold nanoparticles delivery improved photothermal activity and anti-lung carcinoma cells. [PDF]

J Mater Sci Mater Med
Wang Z, Ye M, Wang C, Ma D, Zhang J, Fang F.   +5 more
europepmc   +1 more source

Anti-tumor activity of camptothecin analog conjugate of an RSPO4-based peptibody targeting LGR4/5/6 in preclinical models of colorectal cancer. [PDF]

Br J Cancer
Toh Y, Wu L, Tu J, Liang Z, Aldana AM, Wen JJ, Li L, Pan S, Rowe JH, Hensel ME, Hodo CL, Finch RA, Carmon KS, Liu QJ.   +13 more
europepmc   +1 more source

Chromosome-level genome assembly of Nothapodytes nimmoniana. [PDF]

Sci Data
Wang J, Ma X, Yang X, Yang D, Huang T, Yang Y, Yang Y.   +6 more
europepmc   +1 more source

Insights into Photo Degradation and Stabilization Strategies of Antibody-Drug Conjugates with Camptothecin Payloads. [PDF]

Pharmaceutics
Luo S, Bulos J, Uroza R, Zhao Y, Pan X, Su Y, Qiu H, Olagunju B, Wang W, Liu D, Shameem M.   +10 more
europepmc   +1 more source

Dissecting the Biological Functions of Various Isoforms of Ferredoxin Reductase for Cell Survival and DNA Damage Response. [PDF]

Cells
Nakajima KI, Mohibi S, Hong K, Chen X, Zhang J.   +4 more
europepmc   +1 more source

Ovatifolin Purified from <i>Leptocarpha rivularis</i> Induces Cell Death in A375 and A2058 Melanoma Cancer Cells. [PDF]

Antioxidants (Basel)
Burgos V, Cortez N, Aguilera-Paillán R, Bravo-Bouchat S, Schmidt B, Sperlich E, Pérez R, Rodriguez NM, Ortiz L, Cabrera-Pardo JR, Villegas C, Paz C.   +11 more
europepmc   +1 more source

Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy. [PDF]

Cancer Cell Int
Wang S, Nie Z, Liang L, Zou J, Zhang Z, Wang D, Qu C, Wang C, Jiang J.   +8 more
europepmc   +1 more source

Auranofin attenuates TOPBP1-mediated ATR replication stress response and improves chemotherapeutic response in breast tumor models. [PDF]

J Clin Invest
Ma S, Han Y, Gu R, Chen Q, Guo Q, Yue Y, Cao C, Liu L, Yang Z, Qin Y, Yang Y, Zhang K, Liu F, Liu L, Yang N, Hao J, Yang J, Yao Z, Mao X, Shi L.   +19 more
europepmc   +1 more source

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. [PDF]

Oncogene
Takahashi R, Yamamoto K, Toya H, Shoji H, Kawanishi K, Momosaki K, Yabe M, Takashima K, Muromoto R, Ichikawa S, Matsuda T, Kitai Y.   +11 more
europepmc   +1 more source